as on March 11, 2026 at 6:59 am IST
Day's Low
Day's High
0.30%
Downside
8.48%
Upside
52 Week's Low
52 Week's High
49.14%
Downside
63.54%
Upside
Check Regenxbio Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$437.9M
EPS (TTM)
-2.25
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-2.46
Industry PE ratio
-3.0981227436823104
PEG Ratio
0.26
EBITDA
-145.6M
Revenue (TTM)
170.4M
Profit Margin
-113.75%
Return On Equity TTM
-107.00%
Track how Regenxbio Inc P/E has moved over time to understand its valuation trends.
Regenxbio Inc in the last 5 years
Lowest (-14.61x)
March 31, 2021
Industry (-3.10x)
March 10, 2026
Today (-2.46x)
March 10, 2026
Highest (19.14x)
September 30, 2022
Today’s Price to Earnings Ratio: -2.46x
Compare market cap, revenue, PE, and other key metrics of Regenxbio Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $437.9M | -74.37% | -2.46 | -113.75% | |
| BUY | $42.5B | 140.27% | 137.03 | 8.45% | |
| BUY | $116.0B | 115.07% | 29.85 | 32.94% | |
| NA | $33.3B | NA | 590.43 | 5.37% | |
| BUY | $80.3B | 67.03% | 18.31 | 31.41% |
The Regenxbio Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Regenxbio Inc investment value today
Current value as on today
₹1,69,918
Returns
₹69,918
(+69.92%)
Returns from Regenxbio Inc Stock
₹64,725 (+64.73%)
Dollar Returns*
₹5,192 (+5.19%)
Based on 18 analysts
88.89%
Buy
11.11%
Hold
0.00%
Sell
Based on 18 analysts, 88.89% of analysts recommend a 'BUY' rating for Regenxbio Inc. Average target price of $28
Get share price movements and forecasts by analysts on Regenxbio Inc.
What analysts predicted
64.64%UPSIDE
Target Price
$28
Current Price
$9.9
Analyzed by
18 Analysts
Target
$28.00
Regenxbio Inc target price $28, a slight upside of 64.64% compared to current price of $9.9. According to 18 analysts rating.
Search interest for Regenxbio Inc Stock has decreased by -55% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 11 January
Mon, 01:30 AM
-REGENXBIO announces positive long-term data for Duchenne therapy and outlines key 2026 catalysts, including BLA submission and pivotal trial updates.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Revenue is up for the last 3 quarters, 21.35M → 30.33M (in $), with an average increase of 15.1% per quarter
Price Rise
![]()
In the last 7 days, RGNX stock has moved up by 19.4%
Best in 1 Year
![]()
In the last 1 year, RGNX has outperformed top 5 stocks with highest market-cap in its industry
Against Peers
![]()
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 77.2% return, outperforming this stock by 126.8%
Profit Down
![]()
Netprofit is down for the last 2 quarters, -61.94M → -67.14M (in $), with an average decrease of 8.4% per quarter
| Organisation | Regenxbio Inc |
| Headquarters | 9804 Medical Center Drive, Rockville, MD, United States, 20850 |
| Industry | Health Technology |
| CEO | Mr. Curran M. Simpson M.S. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Ms. Nina Hunter | SVP of Global Regulatory Strategy and Quality |
Mr. Curran M. Simpson M.S. | President, CEO & Director |
Dr. Olivier Danos Ph.D. | Executive VP & Chief Scientific Officer |
Ms. Shiva G. Fritsch | Chief Communications & People Officer |
Ms. Sarah Thomas | Senior Vice President of Quality |
Dr. Ram Palanki Pharm.D. | Executive VP & Chief Commercial Officer |
Mr. Mitchell Chan M.B.A. | Executive VP & CFO |
Mr. Patrick J. Christmas II, J.D. | Executive VP & Chief Strategy and Legal Officer |
Dr. Stephen Pakola M.D. | Executive VP & Chief Medical Officer |
Mr. Craig Malzahn | Executive VP of Product Development & CTO |
Regenxbio Inc share price today is $9.9 as on at the close of the market. Regenxbio Inc share today touched a day high of $10.74 and a low of $9.87.
Regenxbio Inc share touched a 52 week high of $16.19 on and a 52 week low of $5.04 on . Regenxbio Inc stock price today i.e. is closed at $9.9,which is 38.85% down from its 52 week high and 96.62% up from its 52 week low.
Regenxbio Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Regenxbio Inc (RGNX) shares with as little as ₹91.833 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹918.33 in Regenxbio Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Regenxbio Inc share’s latest price of $9.9 as on March 11, 2026 at 1:29 am IST, you will get 1.0101 shares of Regenxbio Inc. Learn more about
fractional shares .
Regenxbio Inc stock has given -74.37% share price returns and 26.32% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?